Indomo

Indomo is a biotechnology company focused on unlocking the intracellular space for large molecule therapeutics. The company's proprietary platform enables the delivery of biologics, such as proteins and antibodies, across the cell membrane to reach previously "undruggable" targets inside the cell. By combining the specificity of biologics with the reach of small molecules, Indomo aims to develop transformative treatments for cancer and other complex diseases. The leadership team includes veterans from Genentech and other leading biopharmaceutical firms. The company is currently in the pre-clinical stage, advancing its platform and initial pipeline candidates.